1. Home
  2. WTFC vs IBRX Comparison

WTFC vs IBRX Comparison

Compare WTFC & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wintrust Financial Corporation

WTFC

Wintrust Financial Corporation

HOLD

Current Price

$136.53

Market Cap

9.7B

Sector

Finance

ML Signal

HOLD

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

HOLD

Current Price

$8.22

Market Cap

8.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WTFC
IBRX
Founded
1991
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
8.4B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
WTFC
IBRX
Price
$136.53
$8.22
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
14
7
Target Price
$164.14
$12.57
AVG Volume (30 Days)
385.9K
26.4M
Earning Date
04-20-2026
05-11-2026
Dividend Yield
1.61%
N/A
EPS Growth
N/A
38.71
EPS
N/A
N/A
Revenue
N/A
$113,288,000.00
Revenue This Year
$13.65
$88.59
Revenue Next Year
$6.33
$131.15
P/E Ratio
$13.60
N/A
Revenue Growth
N/A
668.31
52 Week Low
$89.31
$1.83
52 Week High
$162.96
$12.43

Technical Indicators

Market Signals
Indicator
WTFC
IBRX
Relative Strength Index (RSI) 44.61 50.22
Support Level $127.48 $7.77
Resistance Level $142.32 $8.28
Average True Range (ATR) 3.20 0.85
MACD 0.66 -0.18
Stochastic Oscillator 71.31 55.83

Price Performance

Historical Comparison
WTFC
IBRX

About WTFC Wintrust Financial Corporation

Wintrust Financial Corp is a financial holding company that provides community-oriented, personal, and commercial banking services to customers generally located in the Chicago metropolitan area, southern Wisconsin, northwest Indiana, and western Michigan. The company provides specialty finance services, including financing for the payment of property and casualty insurance premiums and life insurance premiums, and wealth management services to customers in its market area. The company's operations consist of three primary segments: community banking, specialty finance, and wealth management. The company generates the majority of its revenue from the community banking segment.

About IBRX ImmunityBio Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

Share on Social Networks: